Utilità e limiti delia chemioterapia intra-arteriosa nei tumori cerebrali primitivi maligni

Ciric I : Supratentorial gliomas: Surgical considerations and immediate postoperative results. Neurosurgery, 21: 1–10, 1987.

Fadul C : Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology, 38: 1374–1384, 1988.

Vecht CH Jr : The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Phys, 53: 466–475, 1990.

Ammirati : Effect of extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurg, 21: 201–207, 1987.

Winger MJ : Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg, 71: 847–494, 1989.

Organ System Program, National Cancer Institute. Brain Tumor working group report on yhe 9th International Conference on Brain Tumor research and therapy. Journal of Neuro-Oncology, 16: 243–272, 1993.

Paoletti P : Therapy of malignant, brain tumors. Prog Clin Neurosurg, 1: 69–84, 1987.

Harsh GR : Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery, 21: 615–617, 1987.

Soffietti R : Delayed adverse effects after irradiations of gliomas: Clinico-pathological analysis. J Neurooncol, 3: 187–193, 1988.

Mikhael MA : Dosimetric considerations in the diagnosis of radiations necrosis of the brain. In: Radiation damage to the nervous system. A delayed Therapeutic hazard. Gilbert HA Kagan AR , (eds), Raven Press; New York 1980: 59–91.

Marks JE : Cerebral radionecrosis; incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phis, 7: 243–257, 1981.

Kornblith PL : Chemotherapy for malignant gliomas. J Neurosurg, 68: 1–20, 1988.

Stewart DJ : Cisplatin plus cytosine arabinoside in adults with malignant gliomas. J Neuro-Oncol: 2: 29–34, 1984.

Stewart DJ : Cisplatin, arabinofuranosyl cytosine, and caffeine before radiation therapy for glioblastoma. In: Walker MD Thomas DGT , (eds)Biology of brain tumor. Martinus Nijhoff, Boston 1986: 393–398.

Levin VA : Phase II study of combined carmustine 5-fluorouracil, hydroxyurea, and 6mercaptopurine (BFHM) for the treatment of malignant gliomas. Cancer Treat Rep, 70: 1271–1274, 1986.

Steward DJ : Novel modes of chemotherapy administration. In: Progress in experimental tumor research. Brain Tumor Therapy, vol 28 Rosemblum ML Wilson CB , (eds), Karger, Basel, 28: 32–50, 1984.

Danova M Gaetani P : Intravenous carboplatin and etoposide for recurrent malignant glioma: A phase II study. Acta Oncologica, 13: 305–309, 1992.

Eckmann WW : A critical evaluation of the principle governing the advantages of intra-arterial infusions. J Pharmacocinet Biopharm, 2: 257–285, 1974.

Fenstermacher JD : Theoretic limitations ofintracarotid infusions in brain tumor chemotherapy. Cancer Treat Rep, 61: 519–526, 1977.

Levin VA : Pharmacocinetics of intracarotid artery 15C-BCNU in the squirrel monkey. J Neurosurg, 48: 587–593, 1978.

Harper GR : Illustration of intraarterial (IA) chemotherapy delivery advantage following intracarotid administration of radiolabeled-2-deoxy-D-glucose. Proc Am Assoc Cancer Res, 24: 1080, 1983.

Tyler JL : Pharmacocinetics of superselective intra-arterial and intravenous 11C-BCNU evaluated by PET. J Nucl Med, 27: 775–780, 1986.

Theron J : Superselective intracerebral chemotherapy of malignant tumors with BCNU. Neuroradiology, 28: 118–125, 1986.

Ginos JZ : 13N9 Cisplatin PET to asses pharmacocinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors. J Nucl Med, 28: 1844–1852, 1987.

Greenberg HS : Infra-arterial BCNU chemotherapy for treatment of malignant gliomas of central nervous system. J Neurosurg, 61 (3): 423–429, 1984.

Dean MRE : Percutaneous intra-arterial chemoterapy in the treatment of intracranial neoplasms: A review of 36 cases. Br J Radiol, 40: 828–833, 1967.

De Wys WD : Report of vasculitis and blidness after in tracarotid injection of 1,3-bis (2-chloroethyl)-I-nitrosourea (BCNU; NSC-409962) in dogs. Cancer-Chemother Rep, 57: 33–40, 1973.

Omojola MF : Haemorrhagic encephalitis produced by selective non-occlusive intracarotid BCNU iniection in dogs. J Neurosurg, 57: 791–796, 1982.

Kapp J : Limitations, of high-dose intra-arterial BCNU chemotherapy for malignant gliomas. Neurosurgery, 10 (6): 715–719, 1982.

Bremer AM : Complications associated with intracarotid and intravertebral artery BCNU infusion for the treatment of patients with malignant brain tumor (Meeting Abstract). American Association of Neurosurgical Surgeons, 234, 1982.

Shingleton J : Ocular toxicity associated with high dose carmustine. Arch Ophthalmol, 100 (11): 1766–1772, 1982.

Zappoli F Uggetti C : A phase II study of intra-arterial polichemotherapy for malignant gliomas. In: «Ottorino Rossi Award Conference; Convegno Pavese di Neuroradiologia». Zappoli F Martelli A , (eds)Ed Del Centauro, Udine 1992: 61–70.

Zappoli F Farina L : Superselective intra-arterial poly-chemotherapu in adjuvant treatment of malignant neuroepithelial tumors. It J Neurol Sei, 5: 508–509, 1991.

Hochberg FH : The rationale and methodology for intra-arterial chemotherapy with BCNU as tratment for glioblastoma. J Neurosurg, 63 (6): 876–880, 1985.

Wilson CB : Chemotherapy of brain tumours by continuous arterial infusion. Surgery, 55: 640–653, 1964.

Philipps TW : New implantable continuous administration and bolus dose intracarotid drug delivery system for the treatment of malignant gliomas. Neurosurgery, 11: 213–218, 1982.

Schold SC Jr : Treatment of patients with recurrent primary brain tumors with AZQ. Neurology, 34: 615–619, 1984.

Oldfield EH : Reduced systemic drug exposure by combining intraarterial cisdiamminedichloroplatinum (II) with haemodialysis of regional venous drainage. Cancer Res, 47 (7): 1962–1967, 1987.

Clayman DA : Superselective arterial BCNU infusion in the treatment of patients with malignant gliomas. Am J Neuroradiol, 10: 767–771, 1989.

Shapiro WR : A randomized comparison of intraarterial (IA) vs intravenous (IV) BCNU for patients with malignant glioma (Study 8301): Interim analysis demostrating lack of efficacy for IA BCNU. Proc Am Soc Clin Oncol, 6: 69, 1989.

Papavero L : Neuromonitoring (EEG, SSEP anf TCD) during intracarotid infusions of ACNU in patients with anaplastic gliomas. J Eletroencephal Clin Neurophysiol, 1987.

Roosen N : Adjuvant intraarterial chemotherapy with Nimustine in the management of World Health Organization grade IV gliomas of the brain. Cancer, 64: 1984–1994, 1989.

Piana C . Intraarterial Acnu chemotherapy in malignant cerebral gliomas: Preliminary results. Neuroradiology, 33 (Suppl): 319–321, 1991.

Poisson M : Treatment of malignant recurrent glioma by intra-arterial, infra-ophtalmic infusion of HECNU 1-(2 chloroethyl)-l-nitroso-3-(2-hydroxyethyl) urea. A phase II study. J of Neuro-Oncology, 8: 255–262, 1990.

Stewart DI : A phase I study of intracarotid infusion of cid-diamminedichloroplatinum (II) in patients with recurrent malignant intracerebral tumours. Cancer Res, 42 (5): 2059–2062, 1982.

Lavaroni A Leonardi M : Terapia endoarteriosa super-selettiva con carboplatino nei tumori maligni dell'encefalo. In: Neuroradiologia 1991. Rosa ML , (Ed)Ed Del Centauro, Udine 1991, 107–112.

Green SB : Randomized comparison of intraarterial (IA) cisplatin and intravenous (IV) PCNU for the treatment of primary brain tumours (BTCG Study 8420A). Proc Amer Soc Clin Oncol, 8: 86, 1989.

Adams M : A comparison of the toxicity and efficacy of cisplatin and carboplatin in advanced Head and neck cancer. Cancer Treat Rep, 70: 1173–1176, 1986.

Paul AB : (Eds). Carboplatin (JM-8). Current perspectives and future directions. WB Saunders Company Harcourt Brace Jovanovich, Inc, 1990.

Stewart D : Phase I study of intracarotid (IC) carboplatin. Proceeding of ASCO, 9: 90, 1990.

Lynn G Feun : Intracarotid VP1 in malignant brain tumours. J of Neuro-Oncol, 4: 397–401, 1987.

Savaraj N : Clinical pharmacokinetics of intracarotid (IC) VP-16 in primary and metastatic brain tumors. Proc A Soc Clin Oncol, 2: 167, 1983.

Creaven PJ : Clin. Pharmac Ther, 18: 221–226, 1975.

Burchenal JH : Rationale of combination chemotherapy. In: Prestayko AW Croke ST Carter SK , (eds): Cisplatin: Current Status and New Developments. New York, Academic Press, 1980.

Hochberg F : High-doses BCNU with autologus bone marrow rescue for recurrent glioblastoma multiforme. J Neurosurg, 54: 455–460, 1981.

Farina L. Zappoli F : Polichemioterapia intra-arteriosa con carboplatino ed epoposide nei tumori neiroepiteliali maligni. In: «Neuroradiologia», Scotti G , (ed), Milano, 1: 521–526, 1992.

Bernstein M Rutka I : Brain tumor protocols in North America. J. of Neuro Oconology, 17: 231–251, 1993.